These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3002416)

  • 21. Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism.
    Hamasaki T; Sakano T; Kobayashi M; Sakura N; Ueda K; Usui T
    Eur J Clin Invest; 1989 Aug; 19(4):404-11. PubMed ID: 2550242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Source of endogenous arachidonate and 5-lipoxygenase products in human neutrophils stimulated by bradykinin and A23187.
    Nielsen OH; Bukhave K; Ahnfelt-Rønne I; Rask-Madsen J
    Gut; 1988 Mar; 29(3):319-24. PubMed ID: 2833432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.
    Marcus AJ; Broekman MJ; Safier LB; Ullman HL; Islam N; Serhan CN; Weissmann G
    Clin Physiol Biochem; 1984; 2(2-3):78-83. PubMed ID: 6435929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of arachidonic acid by human neutrophils. Characterization of the enzymatic reactions that lead to the synthesis of leukotriene B4.
    Sun FF; McGuire JC
    Biochim Biophys Acta; 1984 Jun; 794(1):56-64. PubMed ID: 6329309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukotriene B4 synthesis and metabolism by neutrophils and granule-free cytoplasts.
    Haines KA; Giedd KN; Weissmann G
    Biochem J; 1986 Jan; 233(2):583-8. PubMed ID: 3082327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro.
    Laviolette M; Coulombe R; Picard S; Braquet P; Borgeat P
    J Clin Invest; 1986 Jan; 77(1):54-60. PubMed ID: 3003154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for generation of leukotriene B4 in human polymorphonuclear leukocytes treated with linoleylanilide.
    Garcia Gil M; Traver J; Suarez C; Marin Cao D; Mato JM
    Biochem Pharmacol; 1984 Oct; 33(20):3303-6. PubMed ID: 6091673
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis.
    Elmgreen J; Nielsen OH; Ahnfelt-Rønne I
    Ann Rheum Dis; 1987 Jul; 46(7):501-5. PubMed ID: 2821934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-lipoxygenase from rat PMN lysate.
    Skoog MT; Nichols JS; Wiseman JS
    Prostaglandins; 1986 Mar; 31(3):561-76. PubMed ID: 3012653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoxygenase products in rabbit polymorphonuclear leukocyte triacylglycerols.
    Bertez C; Sincholle D; Coquelet C; Bonne C
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():33-7. PubMed ID: 6303089
    [No Abstract]   [Full Text] [Related]  

  • 31. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes.
    Shak S; Goldstein IM
    J Biol Chem; 1984 Aug; 259(16):10181-7. PubMed ID: 6088485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 5- and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia.
    Laviolette M; Picard S; Braquet P; Borgeat P
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):191-9. PubMed ID: 3020586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
    Cunningham FM; Wong E; Woollard PM; Greaves MW
    Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukotriene A4, and not leukotriene B4, is the main 5-lipoxygenase metabolite released by bovine leukocytes.
    Sala A; Testa T; Folco G
    FEBS Lett; 1996 Jun; 388(2-3):94-8. PubMed ID: 8690098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.
    Dahl ML; Puustinen T; Uotila P
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):355-65. PubMed ID: 6431565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arachidonic acid metabolism by peripheral blood cells in psoriasis.
    Maurice PD; Allen BR; Heptinstall S; Bather PC
    Br J Dermatol; 1986 May; 114(5):553-66. PubMed ID: 3087403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes.
    Powell WS
    J Biol Chem; 1984 Mar; 259(5):3082-9. PubMed ID: 6321494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotactic lipoxygenase products in sera from patients with psoriasis.
    Fogh K; Ternowitz T; Kragballe K; Herlin T
    Arch Dermatol Res; 1986; 278(3):173-6. PubMed ID: 3015047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors.
    Clancy RM; Dahinden CA; Hugli TE
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of 6-trans isomers of leukotriene B4 to dihydro products by human polymorphonuclear leukocytes.
    Powell WS; Gravelle F
    J Biol Chem; 1988 Feb; 263(5):2170-7. PubMed ID: 2828361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.